.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Cerilliant
Covington
Chubb
US Department of Justice
Johnson and Johnson
Julphar
Moodys
Fish and Richardson

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 7,422,388 protect, and when does it expire?


Patent ► Subscribe protects CHLORAPREP WITH TINT and is included in one NDA.

This patent has ten patent family members in eight countries.

Summary for Patent: ► Subscribe

Title:Applicator for coloring antiseptic
Abstract: Applicators and a method of coloring antiseptics are provided. More specifically, in one embodiment, an applicator having a flexible hollow body containing antiseptic to be applied is provided. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.
Inventor(s): Tufts; Scott A. (El Paso, TX), Flores; Jesus (El Paso, TX), Guzman; Manuel (El Paso, TX)
Assignee: Allegiance Corporation (McGaw Park, IL)
Application Number:11/739,918
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-002May 3, 2005OTCYesYes► Subscribe► SubscribeY USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-005Apr 3, 2006OTCYesYes► Subscribe► SubscribeY USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-007Oct 10, 2006OTCYesYes► Subscribe► SubscribeY USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: ► Subscribe

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,729,786 Liquid applicator for coloring a liquid► Subscribe
7,241,065Applicator for coloring antiseptic► Subscribe
6,991,393Liquid applicator for coloring a liquid► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan4688791► Subscribe
Japan2006520271► Subscribe
Spain2601493► Subscribe
European Patent Office3117866► Subscribe
European Patent Office1610961► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Harvard Business School
Cipla
Argus Health
Queensland Health
Merck
Fuji
Baxter
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot